| Targeted Gene Therapy Provides Relief For Chronic Pain, Study Shows
ScienceDaily (Jan. 24, 2008) Researchers in the Department of Medicine and Department of Neurosciences at Mount Sinai School of Medicine have discovered that chronic pain can be successfully treated with novel targeted gene therapy. In an effort to find a more effective treatment for chronic pain, researchers at Mount Sinai developed a gene therapy technique that simulates the pain-killing effect of opiate drugs. In the new study researchers suggest that gene therapy for pain might in the future become a treatment alternative for patients with severe chronic pain. .
Horsemen talk about boycott
The nucleus of you would go hungry or start getting out of the business," Luchento said. Cat Manzi, one of the track's leading drivers, said the sentiment is that such risk is necessary. "Take a look around. We're dead men walking," Manzi said. Freehold Raceway officials this week said the track will slash its purses for the second time in two months, blaming poor business and the lack of the promised purse supplements. The track also recently cut four jobs from its administrative departments. The Meadowlands is expected to announce purse cuts as well. New Jersey's three major racetracks are largely struggling to make ends meet. Freehold Raceway first cut the amount of purse money it pays out last month, reducing it by 7 percent. Monmouth Park where thoroughbred racing is currently on a seasonal break saw drop-offs in several business categories in 2007.
Who's Blogging
The work appears in yesterday's online edition of the journal Science. Venter said the goal is to design novel microbes whose handcrafted genomes endow them with the ability produce useful chemicals, including renewable synthetic fuels that could substitute for oil. Critics, however, countered that without better oversight of the fledgling field, synthetic biology is more likely to lead to the creation of potent biological weapons and runaway microbes that could wreak environmental havoc. "Venter is claiming bragging rights to the world's longest length of synthetic DNA, but size isn't everything. The important question is not 'How long?' but 'How wise?' " said Jim Thomas of the ETC Group, a Montreal-based group that has called for a moratorium on the release and commercialization of synthetic organisms pending further public debate.
|
